Mikael Dolsten
CIK 1437590 · President R&D · last filed 2026-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$9.21M
Companies
6
Total Filings
116
Lifetime Open-Market Net
-$31.70M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| A | Director | 5,548 | $129.84 | $720.4K | -$606.2K | 8 | 2026-06-02 |
| Apellis Pharmaceuticals, Inc. (APLS) Delisted | Director | 0 | $41.03 | $0 | $0 | 2 | 2026-05-14 |
| RCKTW | Director | 44,220 | $0.01 | $429 | $0 | 3 | 2025-07-18 |
| PFE | President R&D | 323,710 | $26.21 | $8.48M | -$31.09M | 93 | 2024-09-16 |
| KPTI | Director | — | $9.50 | — | $0 | 8 | 2021-05-21 |
| WYETH (WYEp) Delisted | Sr. VP & Pres., Wyeth Research | — | — | — | $0 | 1 | 2008-06-18 |
Recent Filings · Page 4 of 12
116 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-01 | PFE | Mixed | −28,271 | -$956.1K | EDGAR |
| 2020-05-26 | KPTI | Grant (A) | — | $0 | EDGAR |
| 2020-05-19 | PFE | Sell (S) | −95,353 | -$3.60M | EDGAR |
| 2020-03-03 | PFE | Tax (F) | −39,446 | -$1.32M | EDGAR |
| 2020-02-28 | PFE | Mixed | +7,774 | -$1.31M | EDGAR |
| 2019-06-07 | KPTI | Grant (A) | — | $0 | EDGAR |
| 2019-03-05 | PFE | Mixed | −43,362 | -$3.19M | EDGAR |
| 2019-03-01 | PFE | Mixed | +22,410 | -$3.17M | EDGAR |
| 2019-02-26 | PFE | Tax (F) | −54,568 | -$2.34M | EDGAR |
| 2019-02-01 | PFE | Exer (M) | +125,968 | $3.75M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.